QuartrQuartr

KEQU: Sales and earnings declined year-over-year, but backlog and international margins improved

Moins d'1 minute de lecture

First quarter FY2027 saw a 6.7% sales decline and a 44.8% drop in net earnings year-over-year, with backlog rising sequentially but remaining below last year. International segment profitability improved on higher-margin projects, while cost discipline and non-recurring compensation expenses shaped results.

Original document: Kewaunee Scientific Corporation [KEQU] SEC 8-K Current Report — Sep. 9 2026

Clause de non-responsabilité